SARS-CoV-2 infects human brain organoids causing cell death and loss of synapses that can be rescued by treatment with Sofosbuvir
The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is the causative
agent of coronavirus disease 2019 (COVID-19), which was rapidly declared a pandemic by …
agent of coronavirus disease 2019 (COVID-19), which was rapidly declared a pandemic by …
Pluripotent stem cells for spinal cord injury repair
M Martin-Lopez, B Fernandez-Muñoz, S Canovas - Cells, 2021 - mdpi.com
Spinal cord injury (SCI) is a devastating condition of the central nervous system that strongly
reduces the patient's quality of life and has large financial costs for the healthcare system …
reduces the patient's quality of life and has large financial costs for the healthcare system …
Plasminogen activator receptor assemblies in cell signaling, innate immunity, and inflammation
SL Gonias - American Journal of Physiology-Cell …, 2021 - journals.physiology.org
Tissue-type plasminogen activator (tPA) and urokinase-type plasminogen activator (uPA)
are serine proteases and major activators of fibrinolysis in mammalian systems. Because …
are serine proteases and major activators of fibrinolysis in mammalian systems. Because …
Apelin alleviated neuroinflammation and promoted endogenous neural stem cell proliferation and differentiation after spinal cord injury in rats
Q Liu, S Zhou, X Wang, C Gu, Q Guo, X Li… - Journal of …, 2022 - Springer
Background Spinal cord injury (SCI) causes devastating neurological damage, including
secondary injuries dominated by neuroinflammation. The role of Apelin, an endogenous …
secondary injuries dominated by neuroinflammation. The role of Apelin, an endogenous …
[HTML][HTML] Serine proteases and chemokines in neurotrauma: new targets for immune modulating therapeutics in spinal cord injury
Progressive neurological damage after brain or spinal cord trauma causes loss of motor
function and treatment is very limited. Clotting and hemorrhage occur early after spinal cord …
function and treatment is very limited. Clotting and hemorrhage occur early after spinal cord …
[HTML][HTML] Enzymatically inactive tissue-type plasminogen activator reverses disease progression in the dextran sulfate sodium mouse model of inflammatory bowel …
Enzymatically inactive tissue-type plasminogen activator (EI-tPA) does not activate
fibrinolysis, but interacts with the N-methyl-d-aspartate receptor (NMDA-R) and low-density …
fibrinolysis, but interacts with the N-methyl-d-aspartate receptor (NMDA-R) and low-density …
Building on a Solid Foundation: Adding Relevance and Reproducibility to Neurological Modeling Using Human Pluripotent Stem Cells
The brain is our most complex and least understood organ. Animal models have long been
the most versatile tools available to dissect brain form and function; however, the human …
the most versatile tools available to dissect brain form and function; however, the human …
Peptides and methods of using the same
D Austin, C Gelber - US Patent App. 18/454,013, 2024 - Google Patents
XKTZWUACRZHVAN-VADRZIEHSA-N interleukin-8 Chemical compound C ([C@ H](NC (=
O)[C@ H](CC (O)= O) NC (= O)[C@ H](CC= 1C2= CC= CC= C2NC= 1) NC (= O)[C …
O)[C@ H](CC (O)= O) NC (= O)[C@ H](CC= 1C2= CC= CC= C2NC= 1) NC (= O)[C …
Peptides and methods of using the same
D Austin, C Gelber - US Patent 11,779,630, 2023 - Google Patents
US11779630B2 - Peptides and methods of using the same - Google Patents
US11779630B2 - Peptides and methods of using the same - Google Patents Peptides and …
US11779630B2 - Peptides and methods of using the same - Google Patents Peptides and …
Peptides and methods of using the same
D AUSTIN, C Gelber - 2022 - Google Patents
EP4003391A2 - Peptides and methods of using the same - Google Patents EP4003391A2 -
Peptides and methods of using the same - Google Patents Peptides and methods of using …
Peptides and methods of using the same - Google Patents Peptides and methods of using …